How should retinal nerve fiber layer (RNFL) and ganglion cell layer (GCL) thickness be monitored in patients with myopia to detect early signs of glaucoma and other optic neuropathies?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 14, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Monitoring RNFL and GCL Thickness in Myopic Patients for Early Detection of Glaucoma

RNFL and GCL thickness measurements in myopic patients should be interpreted using myopia-specific normative databases rather than standard databases to avoid false-positive errors, particularly in high myopes (≤-6.0D). 1 Both layers thin significantly with increasing myopia, with distinct patterns that must be differentiated from glaucomatous changes.

Comparative Analysis of RNFL and GCL Thickness in Low vs High Myopes

Key Differences in Thickness Patterns

  • RNFL Thickness Patterns:

    • High myopes show significantly thinner quadrantic RNFL profiles compared to low myopes in all quadrants except temporal 2
    • RNFL thinning correlates with spherical equivalent (3.667 μm/diopter) and axial length (-5.3805 μm/mm) 2
    • Superior RNFL regions show the greatest diagnostic ability (AUROC 0.82) for differentiating high myopia 3
  • GCL-IPL Thickness Patterns:

    • Average and minimum GCL-IPL measurements are significantly thinner in high myopes compared to low myopes 2, 3
    • GCL-IPL thinning correlates with spherical equivalent (1.6807 μm/diopter) and axial length (-2.626 μm/mm) 2
    • Superonasal GCL-IPL regions show the highest diagnostic ability (AUROC 0.80) for detecting high myopia 3

Potential Confounders in Measurement and Interpretation

Several factors significantly influence RNFL and GCL thickness measurements in myopic patients:

  1. Axial Length:

    • Critical confounder with strong negative correlation to both RNFL and GCL thickness
    • Each 1mm increase in axial length correlates with approximately 5.38μm decrease in RNFL thickness 2
    • Patients with axial length >24mm show statistically significant thinner RNFL (86.06μm) compared to those with ≤24mm (91.40μm) 4
  2. Optic Disc Area:

    • Larger disc areas correlate with thicker RNFL measurements (9.4617 μm/mm²) 2
    • Notably, optic disc area affects RNFL but not GCL-IPL thickness 2
    • This differential effect creates potential for misinterpretation if not accounted for
  3. Degree of Myopia:

    • Spherical equivalent strongly correlates with both RNFL and GCL-IPL thinning
    • High myopia shows more pronounced thinning in non-temporal RNFL parameters 3
    • Different patterns of thinning occur in moderate vs high myopia 3
  4. Ethnicity:

    • Different ethnic populations may have varying baseline thickness measurements
    • Studies should account for ethnic differences when establishing normative databases

Clinical Relevance and Implications for Monitoring Myopic Patients

Diagnostic Approach for Glaucoma Detection in Myopes

  1. Use of Myopia-Specific Normative Databases:

    • Application of myopia-specific normative databases significantly improves specificity (63.0%-100%) compared to standard databases (8.7%-87.0%) 1
    • This approach reduces false-positive errors without compromising sensitivity 1
  2. Combined RNFL and GCL Assessment:

    • GCL thickness shows strong correlation with RNFL thickness (correlation coefficient=0.763) 5
    • GCL assessment may be superior to RNFL for glaucoma detection in high myopes:
      • GCL measurements show higher AUROC (0.889) than RNFL (0.825) in high myopes 5
      • Superior GCL parameters demonstrate significantly higher sensitivity than superior RNFL 5
  3. Specific Measurement Parameters:

    • Focus on non-temporal RNFL parameters, which are more affected by both myopia and glaucoma 3
    • Pay particular attention to superior and superonasal regions which show highest diagnostic ability 3
    • Consider minimum GCL-IPL values as they show significant correlation with myopia severity 3

Monitoring Recommendations

  1. Baseline Assessment:

    • Obtain comprehensive baseline measurements of both RNFL and GCL thickness
    • Document axial length and optic disc area to account for these confounders
    • Categorize patients by myopia severity: low (<-3.0D), moderate (-3.0D to -6.0D), and high (≤-6.0D)
  2. Follow-up Protocol:

    • More frequent monitoring for high myopes (≤-6.0D) due to greater risk and measurement challenges
    • Use both RNFL and GCL measurements as complementary tools, especially in high myopes 5
    • Compare changes against myopia-specific normative values rather than standard databases 1
  3. Interpretation Cautions:

    • Carefully interpret RNFL data in myopes with axial length >24mm 4
    • Be aware that polar RNFL thinning in high myopes could be misattributed to glaucomatous change 4
    • Consider that optic disc area affects RNFL but not GCL measurements 2

Clinical Pitfalls to Avoid

  1. Overdiagnosis of Glaucoma:

    • Standard normative databases lead to high false-positive rates in high myopes 1
    • RNFL thinning in myopia can mimic glaucomatous patterns, particularly in superior and inferior quadrants 3, 4
  2. Underestimation of Risk:

    • Relying solely on RNFL measurements may miss early glaucomatous changes in high myopes
    • Temporal RNFL is relatively preserved in myopia but may be affected in glaucoma 2, 3
  3. Ignoring Axial Length:

    • Failure to account for axial length can lead to misinterpretation of thinning patterns
    • Critical threshold appears to be around 24mm axial length 4

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.